Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001104659-25-020876
Filing Date
2025-03-05
Accepted
2025-03-05 16:06:44
Documents
8
Effectiveness Date
2025-03-05

Document Format Files

Seq Description Document Type Size
1 POSASR tm258031-1_posasr.htm POSASR 579245
2 EXHIBIT 1.2 tm258031d2_ex1-2.htm EX-1.2 235991
3 EXHIBIT 5.1 tm258031d2_ex5-1.htm EX-5.1 41356
4 EXHIBIT 23.1 tm258031d2_ex23-1.htm EX-23.1 2526
5 EX-FILING FEES tm258031d2_ex-filingfees.htm EX-FILING FEES 69611
6 GRAPHIC tm258031d2_ex5-1img001.jpg GRAPHIC 2146
7 GRAPHIC tm258031d2_ex5-1img002.jpg GRAPHIC 6579
8 GRAPHIC lg_editasmedicine-4c.jpg GRAPHIC 27738
  Complete submission text file 0001104659-25-020876.txt   980466
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

EIN.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-277471 | Film No.: 25710939
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)